课题基金 / 基金详情

Expanding the Scope of Organobismuth Compounds in Organic Synthesis

Expanding the Scope of Organobismuth Compounds in Organic Synthesis
扩大有机铋化合物在有机合成中的应用范围
批准号:
RGPIN-2017-05605
负责人:
Gagnon, Alexandre
金额:
$1.6万
依托单位国家:
加拿大
项目类别:
Discovery Grants Program - Individual
财政年份:
2019
资助国家:
加拿大
项目状态:
已结题
起止时间:
2019-01-01 至 2020-12-31

项目摘要

项目成果

Gagnon, Alexandre的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Bismuth is the 83rd element of the Periodic Table. This heavy metal is the last stable atom of group V of the main p block elements, called the pnictogens. Despite its heavy atomic weight, elemental bismuth shows surprisingly low toxicity. In fact, bismuth-derived compounds have been used as antibiotics, radiopaque bone cements, anticancer agents, drugs for the treatment of gastrointestinal disorders and in many other medicinal applications.******Organobismuth compounds, a class of organometallic reagents that contain a C-Bi bond, are subdivided into two main groups: trivalent and pentavalent organobismuthines where the metal is in the +3 and +5 oxidation state, respectively. A wide diversity of geometries have been found for organobismuth compounds depending on the oxidation state of bismuth (+3, +5), its overall charge (-1, 0, +1, +2) and its number of coordinated elements (3, 4, 5, 6). Due to its lone pair, trivalent organobismuthines can act as sigma-donor ligands in transition metal complexes. In addition, even though bismuth has a full electronic shell, organobismuth compounds can also act as Lewis acids by forming hypervalent interactions with ligands. Due to these remarkable and unique properties, organobismuth compounds have found applications in total synthesis, methodology development, polymerization reactions as well as in 'green', organometallic and medicinal chemistry.******Our group reported protocols to prepare functionalized triaryl, trialkyl and tricyclopropylbismuthines. In particular, we developed an efficient strategy for the synthesis of highly functionalized triarylbismuthines that involves direct triple functional group manipulation directly on the organometallic species. These organobismuth compounds were used in a portfolio of copper-catalyzed arylation, alkylation and cyclopropylation reactions as well as in palladium-catalyzed cross-coupling reactions with aryl/heteroaryl and vinyl halides and triflates. These methods, which lead to the construction of C-C, C-N and C-O bonds, operate under mild conditions, show high functional group tolerance and allow the installation of functionalized groups on medicinally relevant scaffolds.******In this research program, we propose to use the unique properties of organobismuth compounds to develop novel reactions that allow the modification of bioorganic compounds, enable new types of reactions, and give access to synthetically challenging molecules. We will also prepare novel organobismuth compounds that have unique electronic, steric and geometric properties, that possess solubilizing groups, that lead to hypervalency and chirality, and that can find applications in catalysis, electrochemistry, material sciences and tectonics. This program is ideally suited for training highly qualified personnel with multidisciplinary skills in the field of catalysis, organic, organometallic and green chemistry.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Expanding the Scope of Organobismuth Compounds in Organic Synthesis
  • 批准号:
    RGPIN-2017-05605
  • 项目类别:
    Discovery Grants Program - Individual
  • 资助金额:
    $1.6万
  • 财政年份:
    2022
  • 负责人:
    Gagnon, Alexandre
  • 依托单位:
Expanding the Scope of Organobismuth Compounds in Organic Synthesis
  • 批准号:
    RGPIN-2017-05605
  • 项目类别:
    Discovery Grants Program - Individual
  • 资助金额:
    $1.6万
  • 财政年份:
    2021
  • 负责人:
    Gagnon, Alexandre
  • 依托单位:
Expanding the Scope of Organobismuth Compounds in Organic Synthesis
  • 批准号:
    RGPIN-2017-05605
  • 项目类别:
    Discovery Grants Program - Individual
  • 资助金额:
    $1.6万
  • 财政年份:
    2020
  • 负责人:
    Gagnon, Alexandre
  • 依托单位:
Development of a Selective Bromodomain Inhibitor Involved in the SWI/SNF Chromatin Remodeling Complex
  • 批准号:
    543520-2019
  • 项目类别:
    Collaborative Research and Development Grants
  • 资助金额:
    $2.19万
  • 财政年份:
    2019
  • 负责人:
    Gagnon, Alexandre
  • 依托单位:
国内基金
海外基金
SCOPE-AAV-T细胞脑室内注射治疗肺癌脑转移
  • 批准号:
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2024
  • 负责人:
    任军
  • 依托单位: